DTaP vaccine gets FDA nod for fifth dose

Findings indicating that socioeconomic disparities widened gaps in vaccination timeliness signal the need for increased efforts to promote timely vaccination among children from families with lower income and those without private insurance.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

Fasenra was initially approved in 2017 as an add on maintenance therapy in patients aged 12 years and older.

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.

Rilpivirine (Edurant Ped) effectively suppresses the HIV-1 virus in pediatric patients with HIV-1 RNA less than or equal to 100,000 copies/mL in combination with other antiretroviral therapies.